Market Overview:
The global melanoma market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of melanoma, technological advancements in treatment methods, and rising awareness about melanoma. The global melanoma market is segmented by type into chemotherapy, immunotherapy, targeted therapy, and radiation therapy. The chemotherapy segment is expected to dominate the market during the forecast period owing to its high adoption rate for treating various types of cancer including melanoma. Immunotherapy is expected to be the fastest-growing segment during the forecast period due its ability to target specific molecules on tumor cells and induce an immune response against them. The global melanoma market is also segmented by application into hospitals, clinics, and others.
Product Definition:
A malignant tumor that arises from melanocytes, the cells that produce pigment in the skin. Melanomas are relatively rare tumors, but they are often deadly because they can metastasize quickly to other parts of the body. Prevention is important because early detection and treatment can be curative.
Chemotherapy:
Chemotherapy is a medical treatment used to lower the size of abnormal cells (tumor) that can’t be removed by surgery. Chemotherapy may include drugs, biologic therapy, or radiation therapy. The most common types of cancer treated with chemotherapy are skin melanoma and breast cancer.
Immunotherapy:
Immunotherapy is a treatment wherein the body's immune system is stimulated to fight cancerous cells. There are various types of immunotherapies, including checkpoint inhibitors, cytokine therapies, and monoclonal antibodies. The most common type of melanoma that spreads to other parts of the body is known as cutaneous melanoma; it accounts for around 90% of all skin-based moles.
Application Insights:
The others segment held the largest share of 66.7% in 2017. The application includes research institutes and private practices. Other applications include metastatic spread to other organs or sites, recurrence, and death due to melanoma. According to a study published by NCBI in 2018, it was estimated that around 20% of people with advanced disease will die within two years due to the disease itself while 80% of people with early-stage melanoma will live for at least five years after diagnosis if treated appropriately. Thus, increasing awareness about early detection is expected to boost market growth over the forecast period among other factors such as availability of treatment options across all regions coupled with rising incidences globally are anticipated drive this segment over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, increased adoption of immunotherapy and targeted therapy drugs, rising incidence of melanoma, and high healthcare expenditure in this region. In addition, increasing number of FDA approvals for new drug applications for these cancers is also expected to drive growth during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to an increase in patient awareness levels coupled with government initiatives such as “One Health†concept that has unified public health & hospitals with primary care physicians & other healthcare providers across countries such as India and China. These factors are expected to boost treatment options for patients suffering from skin cancer during the forecast period which will further propel market demand over next eight years to 2030 time frame.
Growth Factors:
- Increasing incidence of melanoma
- Growing awareness about melanoma and its symptoms
- Rising demand for better treatment options for melanoma
- Availability of new and innovative therapies for the treatment of melanoma
- increasing research and development investments in the field of melanoma
Scope Of The Report
Report Attributes
Report Details
Report Title
Melanoma Market Research Report
By Type
Chemotherapy, Immunotherapy, Targeted Therapy, Radiation Therapy
By Application
Hospitals, Clinics, Others
By Companies
Amgen, Eristol-Mayers Squibb, Eisai, Roche, Genetech, Janssen Biotech, Pfizer, Novartis, Vical, Ziopharm
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
232
Number of Tables & Figures
163
Customization Available
Yes, the report can be customized as per your need.
Global Melanoma Market Report Segments:
The global Melanoma market is segmented on the basis of:
Types
Chemotherapy, Immunotherapy, Targeted Therapy, Radiation Therapy
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Amgen
- Eristol-Mayers Squibb
- Eisai
- Roche
- Genetech
- Janssen Biotech
- Pfizer
- Novartis
- Vical
- Ziopharm
Highlights of The Melanoma Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Chemotherapy
- Immunotherapy
- Targeted Therapy
- Radiation Therapy
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Melanoma Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Melanoma is a type of skin cancer that can occur anywhere on the body. Melanoma most often occurs in people over the age of 30, but it can also occur in younger people. Melanoma is the most deadly form of skin cancer and has a 5-year survival rate of only 10%.
Some of the major companies in the melanoma market are Amgen, Eristol-Mayers Squibb, Eisai, Roche, Genetech, Janssen Biotech, Pfizer, Novartis, Vical, Ziopharm.
The melanoma market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Melanoma Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Melanoma Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Melanoma Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Melanoma Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Melanoma Market Size & Forecast, 2018-2028
4.5.1 Melanoma Market Size and Y-o-Y Growth
4.5.2 Melanoma Market Absolute $ Opportunity
Chapter 5 Global Melanoma Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Melanoma Market Size Forecast by Type
5.2.1 Chemotherapy
5.2.2 Immunotherapy
5.2.3 Targeted Therapy
5.2.4 Radiation Therapy
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Melanoma Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Melanoma Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Melanoma Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Melanoma Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Melanoma Analysis and Forecast
9.1 Introduction
9.2 North America Melanoma Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Melanoma Market Size Forecast by Type
9.6.1 Chemotherapy
9.6.2 Immunotherapy
9.6.3 Targeted Therapy
9.6.4 Radiation Therapy
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Melanoma Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Melanoma Analysis and Forecast
10.1 Introduction
10.2 Europe Melanoma Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Melanoma Market Size Forecast by Type
10.6.1 Chemotherapy
10.6.2 Immunotherapy
10.6.3 Targeted Therapy
10.6.4 Radiation Therapy
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Melanoma Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Melanoma Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Melanoma Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Melanoma Market Size Forecast by Type
11.6.1 Chemotherapy
11.6.2 Immunotherapy
11.6.3 Targeted Therapy
11.6.4 Radiation Therapy
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Melanoma Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Melanoma Analysis and Forecast
12.1 Introduction
12.2 Latin America Melanoma Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Melanoma Market Size Forecast by Type
12.6.1 Chemotherapy
12.6.2 Immunotherapy
12.6.3 Targeted Therapy
12.6.4 Radiation Therapy
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Melanoma Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Melanoma Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Melanoma Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Melanoma Market Size Forecast by Type
13.6.1 Chemotherapy
13.6.2 Immunotherapy
13.6.3 Targeted Therapy
13.6.4 Radiation Therapy
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Melanoma Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Melanoma Market: Competitive Dashboard
14.2 Global Melanoma Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Amgen
14.3.2 Eristol-Mayers Squibb
14.3.3 Eisai
14.3.4 Roche
14.3.5 Genetech
14.3.6 Janssen Biotech
14.3.7 Pfizer
14.3.8 Novartis
14.3.9 Vical
14.3.10 Ziopharm
